Alpha DNA Investment Management’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,332	Closed	-$424K	–	223
2024 Q3	$424K	Sell	2,332 -226	-9%	-$41.1K	0.16%	159
2024 Q2	$470K	Sell	2,558 -413	-14%	-$75.8K	0.18%	124
2024 Q1	$529K	Buy	+2,971	New	+$529K	0.2%	124